Biotechnology
Kinase Inhibitors: Global Markets
This report will provide:
- An overview of the technologies employed in the pharmacogenomics industry; for each kinase inhibitor type in clinical use, analysis is offered for the evidence of efficacy, technical limitations, and market status
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of the potential for additional novel applications and new competitive threats
- Examination of the role of government regulations, patents, and factors affecting the industry worldwide
- Discussion of how the development of new kinase inhibitors is translating into new medical therapies for specific disease targets, including cancer, heart disease, inflammatory disorders, diabetes, macular degeneration, and neurological disorders
- Comprehensive company profiles of major players in the industry.
Target Date: May 2012 Report ID: BIO053C Report Author: Shalini Shahani Dewan Price: $4,850.00
Biosimilars: Global Markets
- The global market for biosimilars reached $1.7 billion in 2010 and $2.5 billion in 2011. The market is expected to reach $3.6 billion by 2016, a compound annual growth rate (CAGR) of 7.7%.
- The APAC region market for biosimilars reached $605 million in 2010 and $683 million in 2011. The market is expected to reach $1.1 billion by 2016, a CAGR of 10.3%.
- The United States market for biosimilars reached $507 million in 2010 and $1.1 billion in 2011. The market is expected to reach $1.3 billion by 2016, a CAGR of 4.1%.
##img_0##
Target Date: May 2012 Report ID: BIO090A Report Author: Syamala Ariyanchira Price: $4,850.00
Kinase Inhibitors: Global Markets -- Focus on Europe
This report will provide:
- An overview, with a focus on the markets in Europe, of the technologies employed in the pharmacogenomics industry; for each kinase inhibitor type in clinical use, analysis is offered for the evidence of efficacy, technical limitations, and market status
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of the potential for additional novel applications and new competitive threats
- Examination of the role of government regulations, patents, and factors affecting the industry
- Discussion of how the development of new kinase inhibitors is translating into new medical therapies for specific disease targets, including cancer, heart disease, inflammatory disorders, diabetes, macular degeneration, and neurological disorders
- Comprehensive company profiles of major players in the industry.
Target Date: May 2012 Report ID: BIO109A Report Author: Shalini Shahani Dewan Price: $3,900.00
Global Markets for Enzyme Inhibitors
This report will provide:
- An overview of the major current and emerging markets for enzyme inhibitors used in human therapeutics
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Discussion of the biochemistry for enzyme inhibitors and classes of enzyme inhibiting products with broad current or potential therapeutic applications
- A synopsis of more than 100 enzyme inhibitors, including those currently marketed and those in phase two or later development
- An examination of the leading indications for available and emerging enzyme inhibitors; these include selected indications for asthma and chronic obstructive pulmonary disease (COPD), cardiovascular diseases, erectile dysfunction, gastrointestinal disorders, hepatitis B virus infection, hepatitis C virus infection, herpes virus infections, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), and rheumatoid arthritis and related inflammatory diseases
- Comprehensive profiles emphasizing companies that lead the pharmaceutical and biotechnology industries in the research and development of enzyme-inhibiting drugs.
Target Date: May 2012 Report ID: BIO057B Report Author: Shalini Shahani Dewan Price: $4,850.00
Global Markets for Stem Cells
This report will provide:
- An overview of the current status of stem cell technology and its applications
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Discussion of the position of adult stem cell technology and applications as compared to the development and applications of embryonic stem cells
- Evaluations of the market potential of emerging breakthroughs in stem cell research, such as induced pluripotent stem cells (iPS)
- A look forward into emerging advancements in stem cell technology and the potential impact these advancements could have on the development of stem-cell-based products
- Examination of governmental (legal and political) as well as social issues regarding the research and development for therapeutic applications
- Projected status of high-value applications, such as cell-based assays, diagnostic tools, and necessary support reagents and materials
- Comprehensive company profiles of major players.
Target Date: May 2012 Report ID: BIO035D Report Author: Paul Evers Price: $4,850.00
Global Markets for Enzyme Inhibitors -- Focus on the US
This report will provide:
- An overview of the major markets for enzyme inhibitors used in human therapeutics, with a focus on the United States
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Discussion of the biochemistry for enzyme inhibitors and classes of enzyme inhibiting products with broad current or potential therapeutic applications
- A synopsis of more than 100 enzyme inhibitors, including those currently marketed and those in phase two or later development
- An examination of the leading indications for available and emerging enzyme inhibitors; these include selected indications for asthma and chronic obstructive pulmonary disease (COPD), cardiovascular diseases, erectile dysfunction, gastrointestinal disorders, hepatitis B virus infection, hepatitis C virus infection, herpes virus infections, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), and rheumatoid arthritis and related inflammatory diseases
- Comprehensive profiles emphasizing companies that lead the pharmaceutical and biotechnology industries in the research and development of enzyme-inhibiting drugs.
Target Date: May 2012 Report ID: BIO105A Report Author: Shalini Shahani Dewan Price: $3,900.00
Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets
This report will provide:
- An overview of the major markets for enzyme inhibitors used in human therapeutics, with a focus on Emerging Markets
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Discussion of the biochemistry for enzyme inhibitors and classes of enzyme inhibiting products with broad current or potential therapeutic applications
- A synopsis of more than 100 enzyme inhibitors, including those currently marketed and those in phase two or later development
- An examination of the leading indications for available and emerging enzyme inhibitors; these include selected indications for asthma and chronic obstructive pulmonary disease (COPD), cardiovascular diseases, erectile dysfunction, gastrointestinal disorders, hepatitis B virus infection, hepatitis C virus infection, herpes virus infection, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), and rheumatoid arthritis and related inflammatory diseases
- Comprehensive profiles emphasizing companies that lead the pharmaceutical and biotechnology industries in the research and development of enzyme-inhibiting drugs.
Target Date: May 2012 Report ID: BIO107A Report Author: Shalini Shahani Dewan Price: $3,900.00
Global Markets for Enzyme Inhibitors -- Focus on Europe
This report will provide:
- An overview of the major markets for enzyme inhibitors used in human therapeutics, with a focus on Emerging Markets
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Discussion of the biochemistry for enzyme inhibitors and classes of enzyme inhibiting products with broad current or potential therapeutic applications
- A synopsis of more than 100 enzyme inhibitors, including those currently marketed and those in phase two or later development
- An examination of the leading indications for available and emerging enzyme inhibitors; these include selected indications for asthma and chronic obstructive pulmonary disease (COPD), cardiovascular diseases, erectile dysfunction, gastrointestinal disorders, hepatitis B virus infection, hepatitis C virus infection, herpes virus infections, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), and rheumatoid arthritis and related inflammatory diseases
- Comprehensive profiles emphasizing companies that lead the pharmaceutical and biotechnology industries in the research and development of enzyme-inhibiting drugs.
Target Date: May 2012 Report ID: BIO106A Report Author: Shalini Shahani Dewan Price: $3,900.00
Kinase Inhibitors: Global Markets -- Focus on the U.S.
This report will provide:
- An overview, with a focus on the U.S. market, of the technologies employed in the pharmacogenomics industry; for each kinase inhibitor type in clinical use, analysis is offered for the evidence of efficacy, technical limitations, and market status
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of the potential for additional novel applications and new competitive threats
- Examination of the role of government regulations, patents, and factors affecting the industry
- Discussion of how the development of new kinase inhibitors is translating into new medical therapies for specific disease targets, including cancer, heart disease, inflammatory disorders, diabetes, macular degeneration, and neurological disorders
- Comprehensive company profiles of major players in the industry.
Target Date: May 2012 Report ID: BIO108A Report Author: Shalini Shahani Dewan Price: $3,900.00
Kinase Inhibitors: Global Markets -- Focus on Asia
This report will provide:
- An overview, with a focus on the markets in Asia, of the technologies employed in the pharmacogenomics industry; for each kinase inhibitor type in clinical use, analysis is offered for the evidence of efficacy, technical limitations, and market status
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of the potential for additional novel applications and new competitive threats
- Examination of the role of government regulations, patents, and factors affecting the industry
- Discussion of how the development of new kinase inhibitors is translating into new medical therapies for specific disease targets, including cancer, heart disease, inflammatory disorders, diabetes, macular degeneration, and neurological disorders
- Comprehensive company profiles of major players in the industry.
Target Date: May 2012 Report ID: BIO110A Report Author: Shalini Shahani Dewan Price: $3,900.00
Kinase Inhibitors: Global Markets -- Focus on Emerging Markets
This report will provide:
- An overview, with a focus on Emerging Markets, of the technologies employed in the pharmacogenomics industry; for each kinase inhibitor type in clinical use, analysis is offered for the evidence of efficacy, technical limitations, and market status
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of the potential for additional novel applications and new competitive threats
- Examination of the role of government regulations, patents, and factors affecting the industry
- Discussion of how the development of new kinase inhibitors is translating into new medical therapies for specific disease targets, including cancer, heart disease, inflammatory disorders, diabetes, macular degeneration, and neurological disorders
- Comprehensive company profiles of major players in the industry.
Target Date: May 2012 Report ID: BIO111A Report Author: Shalini Shahani Dewan Price: $3,900.00
Global Markets for Diagnosis and Treatment of Neurodegenerative Disorders
This report will provide:
- An overview of the global markets for the diagnoses and treatments for neurogenerative disorders, including syndromes of dementia, syndromes of movement disorders, syndromes of progressive ataxia, and syndromes of progressive weakness and atrophy
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of regulatory issues in North America, Europe, and Emerging Markets
- Evaluations of new developments in the industry and a patent analysis
- Examination of the markets by technology, such as monoclonal antibodies, nanoparticles, smaller molecules, and stem cells
- Comprehensive company profiles of major players.
Target Date: June 2012 Report ID: BIO104A Report Author: Shalini Shahani Dewan Price: $4,850.00
Drug Discovery Technologies
This report will provide:
- An overview of the market for drug discovery technologies, with descriptions of various related products, including bioanalytical instruments, high-throughput screening, informatics, and microarrays
- Analyses of global market trends, with data from 2010, estimates for 2011, and projections of compound annual growth rates (CAGRs) through 2016
- Discussion of new methods of research important to the market, including compound discovery, compound optimization, efficacy testing in vitro and in vivo, toxicology testing, pharmacokinetics, and stability testing
- Analysis of patents and their importance to the industry
- Comprehensive company profiles of major players.
Target Date: June 2012 Report ID: BIO020D Report Author: Marianna Tcherpakov Price: $4,850.00
Single-Use Technologies for Biopharmaceuticals: Global Markets
This report will provide:
- An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns
- Comprehensive company profiles of existing and potential market players
- Patent analysis.
Target Date: June 2012 Report ID: BIO099A Report Author: Mahi Dutta Price: $4,850.00
Agricultural Biotechnology: Emerging Technologies and Global Markets
This report will provide:
- An overview of the global market for agricultural biotechnology, with a breakdown of end-market applications such as crop protection, crop enhancement, livestock health, industrial products, food safety, and agricultural research and development
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Coverage of emerging technologies, such as DNA sequencing, synthetic biology, biochips, RNA interference/gene regulation, nanotechnology, high-throughput assays, rapid detection systems, and DNA vaccines
- Identification of strategies and the emerging tools focus for each of the key competitors in the industry
- Lists of patents by technology and by company
- Comprehensive company profiles of major players.
Target Date: June 2012 Report ID: BIO100A Report Author: John Bergin Price: $4,850.00
Top Ten Companies in DNA Sequencing
highlights to come
highlights to come
Target Date: July 2012 Report ID: BIO112A Report Author: Stephen Weber Price: $2,250.00
Protein Drugs: Global Markets and Manufacturing Technologies
This report will provide:
- An overview of the markets for each major class of protein in therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Examinations of current successes, including the size and sales forecast for each class in the next five years
- Discussion of challenges such as delivery methods and side effects
- Consideration of issues regarding add-on products and patent protection
- Comprehensive company profiles of major players.
Target Date: July 2012 Report ID: BIO021D Report Author: Esther Bosklopper Price: $4,850.00
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
This report will provide:
- An overview of the specific applications for nucleic acid aptamers for therapeutic and diagnostic purposes, with a focus on applications judged to be commercially viable rather than enabling of basic research
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of emerging technology growth opportunities in aptamer use as adjuvants for siRNA delivery, vaccines, and antisense technologies
- Examination of high growth and market potential segments of the industry, and new and established companies in the arena
- Comprehensive company profiles of major players in the industry.
Target Date: August 2012 Report ID: BIO071B Report Author: George W. Jackson Price: $4,850.00
Nanoparticles in Biotechnology, Drug Development and Drug Delivery
highlights to come
highlights to come
Target Date: September 2012 Report ID: BIO113A Report Author: Jackson Highsmith Price: $4,850.00
Global Markets and Technologies for Cell and Tissue Analysis
This report will provide:
- An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms
- Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
- Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products
- Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Target Date: September 2012 Report ID: BIO068B Report Author: Shalini Shahani Dewan Price: $4,850.00
Biologic Imaging Reagents: Technologies and Global Markets
This report will provide:
- An overview of the global market for biologic imaging reagents that are commercial or likely to be commercialized within the next five years
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Coverage of technologies such as fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); fluorescent proteins; supermolecules; contrast reagents for MRI, X-ray, and ultrasound; and imaging radiopharmaceuticals
- Discussion of both the in vivo and in vitro market segments
- Evaluations of industry alliances and acquisitions, and the use of biologic imaging reagents in key diagnostics and R&D tools platforms, including microarrays, lab-on-a-chip devices, DNA sequencing, PCR, and cellular analysis
- Examination of technology status and market driving forces
- Comprehensive company profiles of major players.
Target Date: September 2012 Report ID: BIO064B Report Author: John Bergin Price: $4,850.00
